Cargando…

A review of the pharmacoeconomics of eletriptan for the acute treatment of migraine

Migraine is a commonly occurring, chronic disorder that can cause significant disability. Eletriptan, a selective serotonin 5-hydroxytryptamine 1 receptor subtype B/D (5-HT(1B/1D)) agonist, is a clinically effective treatment for moderate to severe migraine. The objective of this literature review w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhambri, Rahul, Mardekian, Jack, Liu, Larry Z, Schweizer, Edward, Ramos, Elodie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4296958/ https://www.ncbi.nlm.nih.gov/pubmed/25624770 http://dx.doi.org/10.2147/IJGM.S73673

Ejemplares similares

Migraine attacks during menses: efficacy of eletriptan and relationship to recurrence after response
por: Bhambri, Almas, et al.
Publicado: (2013)

Patient satisfaction with eletriptan in the acute treatment of migraine in primary care
por: Nett, R B, et al.
Publicado: (2007)

Synthesis of compounds related to the anti-migraine drug eletriptan hydrobromide
por: Madasu, Suri Babu, et al.
Publicado: (2012)

Eletriptan provides consistent migraine relief: results of a within-patient multiple-dose study
por: Almas, M, et al.
Publicado: (2013)

Eletriptan/paracetamol: Lack of efficacy: case report
Publicado: (2021)

Risk of medication overuse headache across classes of treatments for acute migraine
por: Thorlund, Kristian, et al.
Publicado: (2016)

Pharmacokinetics and tolerability of eletriptan hydrobromide in healthy Korean subjects
por: Kim, Yu Kyong, et al.
Publicado: (2018)

Pharmacoeconomics for migraine and headache researchers: basic concepts, methods and terminology
por: Walley, Tom
Publicado: (2004)

Pharmacoeconomic considerations in the treatment of breast cancer
por: Pallis, Athanasios, et al.
Publicado: (2010)

SAT-192 Eletriptan (Relpaxa(Tm)) Causing False Positive Elevations in Urinary Metanephrine
por: Bloomer, Zachary, et al.
Publicado: (2020)

Systematic review of pharmacoeconomic models for schizophrenia
por: Zhou, Junwen, et al.
Publicado: (2018)

Pharmacoeconomic aspects of the treatment of pituitary gland tumours
por: Sowiński, Jerzy, et al.
Publicado: (2013)

Haemophilia A: Pharmacoeconomic Review of Prophylaxis Treatment versus On-Demand
por: Unim, Brigid, et al.
Publicado: (2015)

Review of the pharmacoeconomics of early treatment of multiple sclerosis using interferon beta
por: Castrop, Florian, et al.
Publicado: (2013)

The pharmacoeconomics of the state-of-the-art drug treatments for asthma: a systematic review
por: Menzella, Francesco, et al.
Publicado: (2021)

Statistically Optimized Polymeric Buccal Films of Eletriptan Hydrobromide and Itopride Hydrochloride: An In Vivo Pharmacokinetic Study
por: Safhi, Awaji Y., et al.
Publicado: (2023)

Pharmacoeconomics in COPD: lessons for the future
por: Starkie, Helen J, et al.
Publicado: (2008)

Essentials of pharmacoeconomics
por: Rascati, Karen L.
Publicado: (2014)

Principles of pharmacoeconomics /
Publicado: (1996)

Economic considerations in the treatment of invasive aspergillosis: a review of voriconazole pharmacoeconomic studies
por: Krueger, Kem P, et al.
Publicado: (2009)

Pharmacoeconomic evaluations in the treatment of actinic keratoses
por: Tolley, Keith, et al.
Publicado: (2017)

Current Trends and Challenges in Pharmacoeconomic Aspects of Nanocarriers as Drug Delivery Systems for Cancer Treatment
por: Milewska, Sylwia, et al.
Publicado: (2021)

Pharmacoeconomics guidelines: The need of hour for India
por: Oberoi, Sukhvinder Singh, et al.
Publicado: (2014)

Pharmacoeconomic Education for Pharmacy Students in Bosnia and Herzegovina
por: Catić, Tarik, et al.
Publicado: (2013)

The Development of Eletriptan Hydrobromide Immediate Release Buccal Films Using Central Composite Rotatable Design: An In Vivo and In Vitro Approach
por: Siddique, Waqar, et al.
Publicado: (2022)

The role of pharmacoeconomics in current Indian healthcare system
por: Ahmad, Akram, et al.
Publicado: (2013)

Principles of pharmacoeconomic analysis: the case of pharmacist-led interventions
por: Tonin, Fernanda S., et al.
Publicado: (2021)

Highly purified chondroitin sulfate: a literature review on clinical efficacy and pharmacoeconomic aspects in osteoarthritis treatment
por: Reginster, Jean-Yves, et al.
Publicado: (2020)

Fluid management: the pharmacoeconomic dimension
por: Vincent, Jean-Louis
Publicado: (2000)

Drug Policy Research & Pharmacoeconomics
Publicado: (2008)

Development of pharmacoeconomics guidelines for India
por: Thomas, Dixon, et al.
Publicado: (2014)

Formulary Management Methods and Pharmacoeconomics
por: Curtiss, Frederic R.
Publicado: (2003)

Pharmacoeconomic Benefits of Antihypertensive Therapy
por: Gonzalez, Edgar R.
Publicado: (2007)

Quality of pharmacoeconomic research in China: A systematic review
por: Ma, Huifen, et al.
Publicado: (2016)

Systematic Review of the Economic Burden of Overt Hepatic Encephalopathy and Pharmacoeconomic Impact of Rifaximin
por: Neff, Guy, et al.
Publicado: (2018)

Pharmacoeconomic Analysis of Clopidogrel in Secondary Prevention of Coronary Artery Disease
por: Cheng, Judy W.
Publicado: (2007)

Barriers and Facilitators of Pharmacoeconomic Studies: A Review of Evidence from the Middle Eastern Countries
por: Alzarea, Abdulaziz Ibrahim, et al.
Publicado: (2022)

Pharmacoeconomic Evaluation of Cancer Biosimilars Worldwide: A Systematic Review
por: Huang, Hui-Yao, et al.
Publicado: (2020)

Grand Challenges in Pharmacoeconomics and Health Outcomes
por: Dubois, Dominique J.
Publicado: (2010)

Pharmacoeconomic studies in Nepal: the need of the hour
por: Acharya, Mahip
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_a0u27lf40cfks9cl0qd362gd7s